Asset Details
Do you wish to reserve the book?
ntravitreal Ranibizumab for Aggressive Posterior Retinopathy of Prematurity
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
ntravitreal Ranibizumab for Aggressive Posterior Retinopathy of Prematurity
Do you wish to request the book?
ntravitreal Ranibizumab for Aggressive Posterior Retinopathy of Prematurity
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
ntravitreal Ranibizumab for Aggressive Posterior Retinopathy of Prematurity
2016
Overview
Retinopathy ofprematurity （ROP） is a proliferative disease that affects infants of young gestational age （GA） and low birth weight （BW）. Aggressive posterior ROP （AP-ROP） is a rapidly progressing and severe presentation of ROP. It is characterized as posterior location （zone 1 or posterior zone I1）, Stage 3, and with plus disease （arterial tortuosity and venous dilation）. It can quickly lead to retinal detachment and blindness if not treated in time.
We currently cannot retrieve any items related to this title. Kindly check back at a later time.